Skip to content
Life sciences consumables, equipment and services, delivered across Saudi Arabia.
Anti-Cannabinoid (THC) Antibody
  • Anti-Cannabinoid (THC) Antibody
Antibodies.com

Anti-Cannabinoid (THC) Antibody

Price on request

SKUPriceQuantity
A34109-1

Price on request

Description

This description has not been verified against the manufacturer's datasheet. Check the datasheet before you order, or ask us to confirm a specification. Ask us to confirm

Sourced from Antibodies.com and distributed through Nordic Biosite, this Sheep polyclonal antibody to Cannabinoid (THC) is supplied as a 1 mg DEAE Purified Ig Fraction in an unconjugated format, intended for use as a primary antibody in ELISA workflows. The reagent is raised in sheep (ovine host) and presents polyclonal clonality, making it well suited to assays that benefit from epitope diversity against tetrahydrocannabinol and related cannabinoid haptens. Researchers commonly deploy this antibody in competitive immunoassay formats for the detection of THC and its metabolites, where polyclonal reagents can provide broad recognition of structurally related analytes. The product ships unconjugated, allowing end users to couple it to enzymes, fluorophores, or biotin according to their own assay design, and it is classified under the Primary Antibodies category. For optimal stability, the purified Ig fraction should be stored according to the manufacturer's recommendations (typically refrigerated short term and frozen in aliquots for long term use) and protected from repeated freeze–thaw cycles to preserve binding activity. Each lot is supplied at 1 mg total protein, providing flexibility for both small-scale screening and larger validation studies. A certificate of analysis and standard quality-control documentation are available on request through the supplier. Researchers seeking a robust, well-characterized polyclonal reagent for cannabinoid immunoassay development will find this Sheep anti-THC antibody from Antibodies.com a practical and versatile choice for ELISA-based detection platforms.